The Pharmaceutical industry has faced several shocks in recent years, including sharp swings in production in India and China, global supply chain distortions, and facing the face the threats posed by the COVID-19 pandemic. Volatility in financial markets, including foreign exchange markets, is adding more complexity to the outlook.

In this exclusive Kantox webinar, we review pharmaceutical companies’ strategies to cope with currency risk in a world where forecasts are less reliable and the need for flexibility becomes ever more pressing. The webinar concludes with a set of ‘best practices’ for FX hedging.

Automate a centralised approach to currency risk management to successfully face any market scenario.